期刊文献+

p53基因第72密码子多态与中国人群肝细胞癌遗传易感性的研究 被引量:8

p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population
原文传递
导出
摘要 目的探讨p53基因第72密码子多态(Arg72Pro)与中国人群肝细胞癌(HCC)遗传易感性的关系。方法采用聚合酶链反应限制性片段长度多态方法,检测507例HCC患者与541例对照组肝正常组织p53Arg72Pro基因型分布及差异。结果HCC组及对照组Pro等位基因频率分别为445%及403%,Pro型的HCC发病风险是Arg型的119倍(95%CI=100~141,P=0053)。与Arg/Arg纯合子相比,Arg/Pro杂合子的HCC风险增加至121倍(95%CI=082~178,P=0341),而Pro/Pro纯合子的HCC风险显著增加至179倍(95%CI=106~301,P=0029)。将Arg/Arg、Arg/Pro和Pro/Pro视为不同的等级,经趋势Armitage检验,存在等位基因剂量效应关系(P=0046)。结论Pro增加HCC发病风险,并呈等位基因剂量效应关系,表明Pro/Pro基因型是中国人的HCC遗传易感因素。 Objective To investigate the possible association between the p53 Arg72Pro polymorphism and susceptibility to hepatocellular carcinoma (HCC) in Chinese population. Methods Genomic DNA of the normal liver tissues was extracted from 507 patients with HCC confirmed by histopathological examination and 541 patients with benign liver diseases. PCR-based restriction fragment length polymorphism (RFLP) method was used to determine the p53 Arg72Pro genotypes. Odds ratios (ORs) for HCC and 95% confidence intervals (CIs) from unconditional logistic regression models were used to evaluate the relative risks. Potential HCC risk factors were included in the logistic regression models as covariates in the multivariate analyses on genotype and HCC risk.Results The frequencies for Pro and Arg alleles were 0.445 and 0.555 respectively in the HCC cases, and 0.403 and 0.597 respectively in the controls. The Pro allele was marginally significantly associated with the presence of HCC (P=0.053) and had an increased risk for HCC (OR=1.19, 95% CI=1.00-1.41) as compared to the Arg allele. Carriers of the Pro, or the “risk” allele, had a 1.33-fold increased risk (95% CI=0.92-1.92, P=0.133) of HCC compared to the Arg-only carriers. Compared to Arg/Arg homozygote, Arg/Pro heterozygote had a 1.21-fold increased risk (95% CI=0.82-1.78, P=0.341), whereas Pro/Pro homozygote had a 1.79-fold increased risk (95% CI=1.06-3.01, P=0.029) of HCC (Armitage′s trend test, P=0.046).Conclusion The Pro allele of p53 Arg72Pro is associated with the presence of HCC and Pro/Pro homozygote is potentially one of the risk genetic risk factorss for HCC in Chinese populationa.
出处 《中华医学杂志》 CAS CSCD 北大核心 2005年第2期76-79,共4页 National Medical Journal of China
基金 国家自然科学基金资助项目(30370645) 上海市卫生系统百名优秀跨世纪学科带头人培养计划资助项目(98BR007)
关键词 P53基因 第72密码子多态 中国人群 肝细胞癌 遗传易感性 Liver cancer Gene, p53 Genetic polymorphism Genetic susceptibility
  • 相关文献

参考文献18

  • 1张蕾,邢德印,何祖根,林东昕.p53基因第72位密码子多态与食管癌风险[J].中华医学遗传学杂志,2002,19(1):10-13. 被引量:17
  • 2张健慧,李琰,王瑞,温登瑰,吴明利,何明.中国人食管癌及肺癌发病风险与p53基因多态性[J].中华肿瘤杂志,2003,25(4):365-367. 被引量:30
  • 3方福德.基因多态性与疾病相关性的遗传分析中某些值得注意的问题[J].中华医学杂志,2004,84(10):796-798. 被引量:9
  • 4Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature, 1998, 393: 229-234.
  • 5Lee JM, Lee YC, Yang SY, et al. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer, 2000, 89: 458-464.
  • 6Leveri M, Gritti C, Rossi L, et al. Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients. Cancer Lett, 2004, 208: 75-79.
  • 7Anzola M, Cuevas N, Lopez-Martinez M, et al. Frequent loss of p53 codon 72 Pro variant in hepatitis C virus-positive carriers with hepatocellular carcinoma. Cancer Lett, 2003, 193: 199-205.
  • 8Yu MW, Yang SY, Chiu YH, et al. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology, 1999, 29: 697-702.
  • 9Beckman G, Birgander R, Sjalander A, et al. Is p53 polymorphism maintained by natural selection? Hum Hered, 1994, 44: 266-270.
  • 10Thomas M, Kalita A, Labrecque S, et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol, 1999, 19: 1092-1100.

二级参考文献43

  • 1Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci, 2000,910:121-137.
  • 2Thomas M, Kalita A, Labrecque S, et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol,1999,19:1092-1100.
  • 3Pierce LM, Sivaraman L, Chang W, et al. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. Cancer Epidemiol Biomarkers Prey, 2000,9: 1199-1204.
  • 4Fan R, Wu MT, Miller D, et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomatkers Prev, 2000, 9: 1037-1042.
  • 5Peixoto Guimaraes D, Hsin Lu S, Snijders P, et al.Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett, 2001,162:231-235.
  • 6Lee JM, Lee YC, Yang SY, et al. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esoohagus. Int J Cancer, 2000,89:458-464.
  • 7Storey A, Thomas M, Kalita A, et al. Role of a p53 polymerphism in the development of human papillomavirus-associated cancer. Nature,1998,393 : 229-234.
  • 8Tandle AT, Sanghvi V, Saranath D. Determination of p53 genotype in oral cancer patients from India. Br J Cancer, 2001,84:739-742.
  • 9O'Connor DP, Kay EW,Leader M, et al. p53 codon 72 polymorphism and human papillomavirus associated skin cancer. J Clin Pathol, 2001,54: 539-542.
  • 10Buller RE, Sood A, Fullenkamp C, et al. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis. Cancer Gene Ther, 1997,4: 239-245.

共引文献46

同被引文献79

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部